David Auld - DR Horton Pres CEO

HO2 Stock  EUR 134.10  2.98  2.27%   

CEO

David Auld is Pres CEO of DR Horton
Age 67
Phone817 390 8200
Webhttps://www.drhorton.com

David Auld Latest Insider Activity

Tracking and analyzing the buying and selling activities of David Auld against DR Horton stock is an integral part of due diligence when investing in DR Horton. David Auld insider activity provides valuable insight into whether DR Horton is net buyers or sellers over its current business cycle. Note, DR Horton insiders must abide by specific rules, including filing SEC forms every time they buy or sell DR Horton'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

DR Horton Management Efficiency

The company has return on total asset (ROA) of 0.1687 % which means that it generated a profit of $0.1687 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3128 %, meaning that it generated $0.3128 on every $100 dollars invested by stockholders. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities.
DR Horton has accumulated 6.07 B in total debt with debt to equity ratio (D/E) of 37.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. DR Horton has a current ratio of 7.04, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DR Horton until it has trouble settling it off, either with new capital or with free cash flow. So, DR Horton's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DR Horton sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HO2 to invest in growth at high rates of return. When we think about DR Horton's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Cameron McIntyreCARSALESCOM
N/A
Horton, Inc. operates as a homebuilding company in East, Midwest, Southeast, South Central, Southwest, and West regions in the United States. Horton, Inc. was founded in 1978 and is based in Arlington, Texas. D R operates under Residential Construction classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8437 people. DR Horton (HO2) is traded on Frankfurt Exchange in Germany and employs 13,237 people.

Management Performance

DR Horton Leadership Team

Elected by the shareholders, the DR Horton's board of directors comprises two types of representatives: DR Horton inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HO2. The board's role is to monitor DR Horton's management team and ensure that shareholders' interests are well served. DR Horton's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DR Horton's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Montano, Corp VP
Aron Odom, VP Controller
Donald Horton, Chairman
Jessica Hansen, VP Relations
David Auld, Pres CEO
Bill Wheat, Ex CFO
Paul Romanowski, Ex CoCOO
Collin Dawson, VP Treasurer
Michael Murray, Ex CoCOO
Matt Farris, Pres Region

HO2 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DR Horton a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in HO2 Stock

When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in HO2 Stock please use our How to Invest in DR Horton guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.